| Page 362 | Kisaco Research

From Competitors to Collaborators: Co-operative Pharmaceutical Developments & Health Equity Solutions

Platforming the tangible successes pharmaceutical companies are having to improve DEI in clinical trials.
Highlighting data-driven strategies to improve site capabilities for underserved-patient engagement, recruitment, and experience.
The importance of collaboration and standardization from a large-scale initative perspective, where are we at and where do we need to be.

Senior Director & Head, Global Demographics & Diversity

GSK

Executive Director, Diversity & Inclusion in Clinical Trials

Sanofi

Patient Perspectives: Progressing Health Equity and Empowering Underserved Communities

Patients are the quality control of health equity developments, sharing experiences of clinical trial participation, highlighting the successes of improved patient experience.
What can the industry learn from patient experts, discussing the implementation of patient voice into health equity strategic programs.
Includes an open Q&A towards the end of the panel to ask critical questions to patients and facilitate industry learning.

health equity